Abstract：【Objective】To investigate the effect of colchicine on early recurrence and inflammatory factors after catheter ablation of paroxysmal atrial fibrillation (AF).【Methods】A total of 80 patients with paroxysmal AF who had received catheter ablation were randomly divided into treatment group (n=40, colchicine group) and control group (n=40, placebo group).Three month after the ablation treatment, the early recurrence rate of paroxysmal AF were determined.Changes of the serum high sensitivity C-reactive protein (hs-CRP) and interleukin-6(IL-6 )levels were observed before and after the ablation treatment. 【Results】After ablation, the recurrence rate of the observation group was lower than that of the control group (P<0.05). The levels of hs-CRP and IL-6 in the observation group were significantly lower than those in the control group (P<0.05), and compared with preoperative, postoperative hs-CRP and IL-6 levels were decreased in the observation group (P<0.05), the level of hs-CRP and IL-6 in the control group was higher than that before operation (P<0.05). The treatment group was further divided into recurrent group and non recurrent group, the postoperative recurrence rate of hs-CRP and IL-6 in the non recurrence group was greater than that in the recurrence group (P<0.05).【Conclusion】 Colchicine can prevent early recurrence of paroxysmal AF after catheter ablation treatment. This effect seems to be associated with a significant decrease in inflammatory reaction.
杨华;许臣洪;李欣. 秋水仙碱对阵发性心房颤动导管消融术后早期复发及炎性因子的影响[J]. 医学临床研究, 2016, 33(10): 1979-1981.
YANG Hua, XU Chen-hong, LI Xin. Effect of Colchicine on Early Recurrence and Inflammatory Factors after Catheter Ablation of Paroxysmal Atrial Fibrillation (AF). JOURNAL OF CLINICAL RESEARCH, 2016, 33(10): 1979-1981.
[1] Li J,Solus J,Chen Q, et a1.Role of inflammation and oxidative stress in atrial fibrillation[J], Heart Rhythm,2010,7(4):438-444. [2] 黄从新,张澍,马长生,等.心房颤动:目前的认识和治疗建议--2012[J].中华心律失常学杂志,2012,16(4):246-289. [3] Anderson JL,Halperin JL,Albert NM,et al.Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011ACCF/AHA/HRS recommendations):a report of the ACC/AHA task force on practice guidelines[J].Circulation,2013, 127(18): 1916-1926. [4] Aviles RJ, Martin DO, Apperson-Hansen C, et a1. Inflammation as a risk factor for atrial fibrillation[J].ACC Curr J Rev, 2004, 13(3): 3006-3010. [5] Cai L, Yin Y,Ling Z,et al.Predictors of late recurrence of atrial fibrillation after catheter ablation [J].Int J Cardiol,2013,164(1):82-87. [6] Richter B,Gwechenberger M, Socas A,et al.Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation[J]. Clin Res Cardiol, 2012,101(3):217-225. [7] 刘书旺,米琳,余飞,等.心房颤动导管消融术后早期复发与炎症反应的关系[J].中国介入心脏病学杂志,2010,18(4):181-184. [8] Crittenden DB, Lehmann RA, Schneck L, et al. Colchicine Use Is Associated with Decreased Prevalence of Myocardial Infarction in Patients with Gout[J]. J Rheumatol,2012,39(7): 1458- 1464. [9] Deftereos S, Giannopoulos G, Raisakis K, et al. Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients[J]. J Am Coll Cardiol, 2013, 61(16):1679- 1685. [10] Imazio M, Brucato A, Rovere ME, et al. Colchicine prevents early postoperative pericardial and pleural effusions[J]. Am Heart J, 2011, 162(7): 527-532. [11] Koyama T,Tada H,Sekiguchi Y,et al.Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation:a randomized controlled trial[J]. J Am Coll Cardiol,2010(18),56:1463-1472. [12] Imazio M, Brucato A, Ferrazzi P, et al. Colchicine Reduces Postoperative Atrial Fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy[J]. Circulation, 2011, 124(21): 2290-2295.
2016, Vol. 33 
